Respiri Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

288.48

EPS

—

Div Yield, %

—

Shrs. gr., 5y

15.31%

Rev. gr., 5y

-14.94%

Revenues

457k

+547.80%

Net income

-7m

L+23.44%

CFO

-7m

L+47.91%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Based in Melbourne, Australia, Respiri Limited operates as an e-health software-as-a-service (SaaS) provider. The company is dedicated to the research, development, and commercialization of medical devices across Australia, and also creates, manufactures, and distributes mobile health applications. Its key offerings include wheezo, an innovative electronic tool specifically designed for identifying wheezing in children, along with the Respiri mobile application and the Respiri health portal. The organization officially became Respiri Limited in December 2015, having previously conducted business as iSonea Limited.

URL

http://respiri.com.au/

IPO date

Jul 14, 2000

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title AUD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY
Title AUD in thousands, except ratios and share amounts	2024‑06	2023‑06	2022‑06	2021‑06	2020‑06	2019‑06	2018‑06	2017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT